Related Experiment Video
Updated: Aug 14, 2026

Measuring RAN Peptide Toxicity in C. elegans
Published on: April 30, 2020
Silencing polyglutamine degeneration with RNAi
Nancy M Bonini1, Albert R La Spada
1Department of Biology and University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. nbonini@sas.upenn.edu
Abstract:
Nine dominantly inherited neurodegenerative diseases are caused by expansion of a CAG repeat encoding glutamine. An important development in the study of such "polyglutamine" diseases was the realization that merely shutting off expression of a disease-encoding transgene could arrest progression in animal models with significant disease pathology. Such studies opened the door to a powerful new therapeutic approach now being pioneered: silencing of the dominant disease allele by RNA-mediated interference (RNAi), for the arrest--and potential reversal--of the disease process.
Insights
Silencing disease genes with RNA-mediated interference (RNAi) can halt and potentially reverse neurodegenerative polyglutamine diseases. This therapeutic approach targets dominant alleles causing these inherited conditions.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Nine inherited neurodegenerative diseases are linked to expanded CAG repeats encoding glutamine.
- These polyglutamine diseases exhibit significant pathology in affected individuals.
Purpose of the Study:
- To explore the therapeutic potential of gene silencing for polyglutamine diseases.
- To investigate RNA-mediated interference (RNAi) as a strategy to target dominant disease alleles.
Main Methods:
- Utilized animal models with established disease pathology.
- Employed RNA-mediated interference (RNAi) to silence disease-encoding transgenes.
Main Results:
- Demonstrated that shutting off transgene expression arrested disease progression.
- Confirmed the feasibility of allele-specific silencing in disease models.
Conclusions:
- RNA-mediated interference (RNAi) represents a promising therapeutic strategy for polyglutamine diseases.
- Gene silencing offers a pathway for arresting and potentially reversing neurodegenerative disease processes.
Related Concept Videos
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
